Ying (Ingrid) Ou is a seasoned professional in pharmacology and toxicology, with a notable career spanning over a decade in various leadership roles. Most recently, Ying served as Executive Director at BeiGene from September 2017 to September 2021. Prior positions include Senior Director of Clinical Pharmacology at Onyx Pharmaceuticals/Amgen, and Associate Director/Principal Scientist at Theravance. Ying also held significant roles at Roche Pharmaceuticals Palo Alto and ALZA/Johnson & Johnson as a Principal Scientist and Senior Scientist Clinical Pharmacologist, respectively, focusing on DMPK modeling and clinical pharmacology. Ying earned a Ph.D. in Pharmacology and Toxicology from the University of Washington - School of Medicine.
This person is not in any teams
This person is not in any offices